Cible Skin has secured a significant minority investment from Verlinvest to accelerate its growth and product development in key markets such as Europe, China, and the United States.

Information on the Target

Cible Skin, founded in 2015 by Dr. Raphaël Aknin and entrepreneur Jean Ginefri, is a pioneering skincare brand dedicated to utilizing the science of cell immunity and rejuvenation for optimal skincare results. With a commitment to rigorous research and high-quality formulations, Cible Skin produces its products in France using only the finest natural and active ingredients. The brand offers a comprehensive range of skincare solutions, including cleansers, serums, and moisturizers, as well as exclusive treatments at its flagship clinic in Paris, La Maison Cible Skin, where customers receive personalized care and scientifically-informed guidance.

Central to Cible Skin’s success is its Scientific Committee, guided by Dr. Aknin, which leverages decades of expertise in regenerative medicine and immunological science. This innovative approach enhances the skin's immune system, enabling it to better protect, regenerate, and repair itself, leading to impressive anti-aging and moisturizing outcomes.

Industry Overview in France

The beauty and personal care industry in France is one of the largest sectors in the European market, characterized by a strong emphasis on luxury and quality. Consumers are increasingly seeking products that not only enh